SPRAVATO® Treatment Milwaukee, WI
SPRAVATO® Treatment at Edelica Health
A New Option for Treatment-Resistant Depression
If you have been struggling with treatment-resistant depression (TRD) and traditional antidepressants haven’t worked, SPRAVATO® (esketamine) may be the breakthrough treatment you’ve been looking for. Edelica Health is now offering SPRAVATO® as part of our commitment to providing innovative, evidence-based treatments for mental health.
What is SPRAVATO®?
SPRAVATO® is an FDA-approved prescription nasal spray containing esketamine, a form of ketamine, designed to help adults with TRD. Unlike traditional antidepressants that can take weeks to work, SPRAVATO® targets NMDA receptors in the brain and may provide relief within hours or days for some patients. This groundbreaking treatment is designed to address depression at a neurological level, helping to rebuild lost connections in the brain and promote long-term relief.
How Does SPRAVATO® Work?
SPRAVATO® is believed to restore neural connections in the brain affected by long-term depression. It works differently from traditional antidepressants by modulating glutamate, an essential neurotransmitter involved in mood regulation. Patients who have not responded to standard treatments may find that SPRAVATO® provides rapid and significant improvement in depressive symptoms.
Because SPRAVATO® can cause temporary dissociation or dizziness, it must be administered in a medical setting under the supervision of trained professionals. At Edelica Health, we provide a safe and supportive environment for your treatment sessions.
Who is Eligible for SPRAVATO®?
SPRAVATO® may be right for you if:
- You have been diagnosed with treatment-resistant depression.
- You have tried at least two different antidepressants without significant improvement.
- You are currently under the care of a mental health professional who can oversee your treatment.
- You are seeking an FDA-approved alternative to traditional antidepressants.
What to Expect During Treatment
- Supervised Administration: SPRAVATO® is only available through certified treatment centers like Edelica Health and must be taken in our clinic.
- Session Duration: Each session lasts about two hours, including post-dose monitoring.
- Treatment Plan: Typically, treatments are scheduled twice a week for the first four weeks, then once a week or less as part of a maintenance plan.
- Possible Side Effects: Some patients may experience dizziness, dissociation, nausea, or mild sedation. These effects typically subside within a short period after treatment.
Why Choose Edelica Health for SPRAVATO®?
- Experienced Providers: Our team specializes in innovative treatments for mood disorders, ensuring expert care.
- Compassionate Care: We create a supportive, calming environment where your well-being is our top priority.
- Evidence-Based Approach: We integrate the latest research into our treatment plans, offering you the most advanced care available.
Accepted Insurance
At Edelica Health, we strive to make SPRAVATO® treatment accessible to those who need it. We currently accept:
Our team can assist with verifying your insurance coverage and discussing payment options to help you navigate the process smoothly.
Frequently Asked Questions
Next Steps: Get Started with SPRAVATO®
If you’re interested in learning whether SPRAVATO® is right for you, schedule a consultation today. Our team will walk you through the process, discuss eligibility, and answer any questions.
Contact Us to take the next step toward relief from treatment-resistant depression.
Request Your Consultation Today
Request A Consultation